Human NR1I2 cDNA Clone in Mammalian Expression Vector
Quick Overview for Human NR1I2 cDNA Clone in Mammalian Expression Vector (ABIN3379160)
Gene
Application
Insert
Vector
Vector Backbone
Promoter
Bacterial Resistance
Expression Type
-
-
Species
- Human
-
Supplier Product No.
- sc109997
-
Supplier
- OriGene
-
Purpose
- Untagged full-length cDNA clone from Human NR1I2 is ideal for over-expression of native protein for functional studies.
-
Specificity
- Restriction Site: NotI-NotI
-
Characteristics
-
- These cDNA clones are isolated from full-length cDNA libraries and usually contain the coding sequence as well as the untranslated regions (UTRs) of the mRNA transcript appropriate to the library from which they were isolated.
- These cDNA clones are ideal for over-expression of native proteins for functional studies. Provided as 10 μg transfection-ready plasmids.
- Every lot of primer is tested to provide clean sequencing of cDNA clones.
-
Purification
- The DNAs were purified using PowerPrep HP Plasmid isolation kits for transfection ready plasmids.
-
Components
-
- The cDNA clone is shipped in a 2-D bar-coded Matrix tube as dried plasmid DNA.
- The package also includes 100 pmols of both the corresponding 5' and 3' vector primers in separate vials.
-
Insert Length
- 2930 bp
-
Sequencing Primer
- VP1.5 (forward) 5'GGACTTTCCAAAATGTCG 3', XL39 (reverse) 5'ATTAGGACAAGGCTGGTGGG 3'
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Storage
- RT,-20 °C
-
Storage Comment
- The lyophilized plasmid is stable for up to one year when stored at ambient temperature. Following dissolution in 100 μL dH2O, store at -20 °C. Lyophilized primers are stable for up to one year when stored at ambient temperature. Following dissolution in 10 μL dH2O, store at -20 °C.
-
Expiry Date
- 12 months
-
-
-
: "Cross-talk between EPAS-1/HIF-2α and PXR signaling pathway regulates multi-drug resistance of stomach cancer cell." in: The international journal of biochemistry & cell biology, Vol. 72, pp. 73-88, (2016) (PubMed).
: "Bortezomib and ixazomib protect firefly luciferase from degradation and can flaw respective reporter gene assays." in: Analytical biochemistry, Vol. 509, pp. 124-9, (2016) (PubMed).
: "Desmethyl bosentan displays a similar in vitro interaction profile as bosentan." in: Pulmonary pharmacology & therapeutics, Vol. 30, pp. 80-6, (2015) (PubMed).
: "Obatoclax as a perpetrator in drug-drug interactions and its efficacy in multidrug resistance cell lines." in: The Journal of pharmacy and pharmacology, Vol. 67, Issue 11, pp. 1575-84, (2015) (PubMed).
: "3-Hydroxyflavone and structural analogues differentially activate pregnane X receptor: Implication for inflammatory bowel disease." in: Pharmacological research, Vol. 100, pp. 64-72, (2015) (PubMed).
: "Pharmacokinetic interaction profile of riociguat, a new soluble guanylate cyclase stimulator, in vitro." in: Pulmonary pharmacology & therapeutics, Vol. 28, Issue 2, pp. 130-7, (2014) (PubMed).
: "Induced CYP3A4 expression in confluent Huh7 hepatoma cells as a result of decreased cell proliferation and subsequent pregnane X receptor activation." in: Molecular pharmacology, Vol. 83, Issue 3, pp. 659-70, (2013) (PubMed).
-
-
- NR1I2 (Nuclear Receptor Subfamily 1, Group I, Member 2 (NR1I2))
-
Alternative Name
- NR1I2
-
Background
- This gene product belongs to the nuclear receptor superfamily, members of which are transcription factors characterized by a ligand-binding domain and a DNA-binding domain. The encoded protein is a transcriptional regulator of the cytochrome P450 gene CYP3A4, binding to the response element of the CYP3A4 promoter as a heterodimer with the 9-cis retinoic acid receptor RXR. It is activated by a range of compounds that induce CYP3A4, including dexamethasone and rifampicin. Several alternatively spliced transcripts encoding different isoforms, some of which use non-AUG (CUG) translation initiation codon, have been described for this gene. Additional transcript variants exist, however, they have not been fully characterized. [provided by RefSeq, Jul 2008].Transcript Variant: This variant (1) contains an alternate 5' terminal exon compared to transcript variant 2, and initiates translation from an in-frame, downstream non-AUG (CUG) codon, resulting in a shorter isoform (1) with a different N-terminus compared to isoform 2.
-
NCBI Accession
- NM_003889, NP_003880
Target
-